---
title: "FimH lectin-domain point mutations R60P, Q133K and Y137A: predicted stability versus MD dynamics"
id: "biorxiv-4-point-mutations-in-the-fimh-lectin-domain-predicted-folding-stability-versus"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-4-point-mutations-in-the-fimh-lectin-domain-predicted-folding-stability-versus"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1?rss=1"
published_at: "2026-11-15T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# FimH lectin-domain point mutations R60P, Q133K and Y137A: predicted stability versus MD dynamics
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-4-point-mutations-in-the-fimh-lectin-domain-predicted-folding-stability-versus
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1?rss=1)
- **Published At:** 2026-11-15T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors compared the isolated apo lectin domain of **FimH** (PDB 4XO8) to three point mutants: **R60P**, **Q133K** and **Y137A**. - They ran three independent 500-ns molecular dynamics replicates per system (total reported as 6 microseconds across all systems); the replicate was treated as the unit of analysis (n = 3). - Folding-stability predictions were generated with three tools: FoldX, a Cartesian-ddG-style Rosetta protocol, and ERIS-2. - FoldX and ERIS-2 provided a consistent variant ranking: **R60P** most destabilising, **Q133K** near-neutral; Rosetta produced an anomalously high value for Q133K. - All simulated systems remained folded across the trajectories; no global unfolding was observed in any replicate. - Structural perturbation reproducibly appeared only for **R60P**, which lost beta-strand structure at residues 60–61 and three local hydrogen bonds in replicated observations. - For **Y137A**, the authors did not observe Thr158 moving into the binding pocket in the apo lectin domain simulations. - **Q133K** converted a Gln133–Asp54 polar contact into a Lys133–Asp54 salt bridge during dynamics, as reported by the authors. - Principal-component analysis of conformational space showed departures from the WT region driven by individual replicates (not a consistent variant-wide shift): specifically Y137A replicate 1 and Q133K replicates 2–3. - The authors cautioned that their results characterise apo lectin-domain dynamics and provide a reproducible basis for interpreting FimH mutations, but do not allow inference of affinity; the study is a preprint and not peer-reviewed.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=4VwqSs2draiCBM00zjWBd03hE0QNc7R.NwMl2q2LkPw-1794800625.3348029-1.2.1.1-AXbSh5d3wMHDGuVGdKKqjbrjRy5pyUwG13fkPsKV8RumgXGF7ZeTPGUzW5BhzeCt) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Point mutations in the FimH lectin domain: predicted folding stability versus conformational dynamics for R60P, Q133K and Y137A Jose Angel Navas Passos, Adan Pereira Tapia, Carlos Velez Duncan, Antistio Alviz Amador doi: https://doi.org/10.64898/2026.11.10.765513 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Jose Angel Navas Passos 1 University of Cartagena; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jose%2BAngel%2BNavas%2BPassos%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Navas%20Passos%20JA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJose%2BAngel%2BNavas%2BPassos%2B) Adan Pereira Tapia 2 Universidad de Cartagena * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Adan%2BPereira%2BTapia%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Pereira%20Tapia%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAdan%2BPereira%2BTapia%2B) Carlos Velez Duncan 2 Universidad de Cartagena * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Carlos%2BVelez%2BDuncan%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Velez%20Duncan%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ACarlos%2BVelez%2BDuncan%2B) Antistio Alviz Amador 2 Universidad de Cartagena * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Antistio%2BAlviz%2BAmador%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Alviz%20Amador%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAntistio%2BAlviz%2BAmador%2B) * For correspondence: aalviza@unicartagena.edu.co * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5964202/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5964202/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5964202/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5964202/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5964202/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5964202/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background. The adhesin FimH attaches uropathogenic Escherichia coli to the urinary epithelium through a force-regulated catch-bond that single lectin-domain substitutions can modulate. How such substitutions reshape the dynamics of the isolated lectin domain, and whether stability predictors anticipate them, is unclear. Methods. We compared the wild-type (WT) lectin domain (PDB 4XO8, apo) with R60P, Y137A and Q133K, using three 500 ns molecular dynamics (MD) replicates per system (6 microseconds total) and three folding-stability predictors (FoldX, a Cartesian-ddG-type Rosetta protocol, ERIS-2). The replicate was the unit of analysis (n = 3), with 95% confidence intervals and a WT replicate-to-replicate control. Results. FoldX and ERIS-2 ranked the variants consistently, R60P most destabilising and Q133K neutral; the Rosetta value for Q133K was anomalously high. All systems stayed folded. R60P gave the only reproduced local change, loss of beta-strand structure at residues 60-61 and of three local hydrogen bonds. Y137A did not bring Thr158 into the pocket, and the Q133K Gln133-Asp54 polar contact became a Lys133-Asp54 salt bridge. In the principal-component landscape, departures from the WT region came from individual replicates (Y137A replicate 1; Q133K replicates 2-3), not a systematic shift. Conclusions. A substitution perturbs local structure most clearly when it breaks a beta-strand (R60P), and the stability predictions and dynamics together give a consistent ranking of the variants, including the first dynamic characterisation of Q133K. The results characterise the apo lectin domain and give a reproducible basis for interpreting FimH mutations, not for inferring affinity. Keywords: FimH; lectin domain; point mutations; molecular dynamics; folding stability (ΔΔG); protein stability prediction; principal component analysis; urinary tract infection. ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.12.766333v1 "A Rare Constitutional Centromeric Expansion of Chromosome 1 in a Phenotypically Normal Individual: A Comprehensive Cytogenetic Study") Posted November 15, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/15/2026.11.10.765513.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.10.765513v1.supplementary-material) [ Data/Code](https://www.biorxiv.org/content/early/2026/11/15/2026.11.10.765513.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Point mutations in the FimH lectin domain: predicted folding stability versus conformational dynamics for R60P, Q133K and Y137A Jose Angel Navas Passos, Adan Pereira Tapia, Carlos Velez Duncan, Antistio Alviz Amador bioRxiv 2026.11.10.765513; doi: https://doi.org/10.64898/2026.11.10.765513 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.10.765513v1%26text%3DPoint%2520mutations%2520in%2520the%2520FimH%2520lectin%2520domain%253A%2520predicted%2520folding%2520stability%2520versus%2520conformational%2520dynamics%2520for%2520R60P%252C%2520Q133K%2520and%2520Y137A "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.10.765513v1%26t%3DPoint%2520mutations%2520in%2520the%2520FimH%2520lectin%2520domain%253A%2520predicted%2520folding%2520stability%2520versus%2520conformational%2520dynamics%2520for%2520R60P%252C%2520Q133K%2520and%2520Y137A "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.10.765513v1%26title%3DPoint%2520mutations%2520in%2520the%2520FimH%2520lectin%2520domain%253A%2520predicted%2520folding%2520stability%2520versus%2520conformational%2520dynamics%2520for%2520R60P%252C%2520Q133K%2520and%2520Y137A%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.10.765513v1%26title%3DPoint%2520mutations%2520in%2520the%2520FimH%2520lectin%2520domain%253A%2520predicted%2520folding%2520stability%2520versus%2520conformational%2520dynamics%2520for%2520R60P%252C%2520Q133K%2520and%2520Y137A "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.10.765513) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.10.765513v1&count=horizontal&via=&text=Point%20mutations%20in%20the%20FimH%20lectin%20domain%3A%20predicted%20folding%20stability%20versus%20conformational%20dynamics%20for%20R60P%2C%20Q133K%20and%20Y137A&counturl=www.biorxiv.org/content/10.64898/2026.11.10.765513v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (45988) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20308) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27574) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://
## Related Clinical Research

- [Structural features of CTSC missense variants linked to Papillon-Lefevre syndrome](https://medichelpline.com/clinical-feed/biorxiv-0-structural-correlates-of-disease-associated-ctsc-variants-in-papillon-lefevre.md)
- [Training background shapes acute exercise-induced extracellular vesicle proteomes in humans](https://medichelpline.com/clinical-feed/biorxiv-5-training-background-shapes-the-exercise-induced-extracellular-vesicle-proteome.md)
- [Motherly Plus trial: Smartphone‑assisted single‑session psychotherapy for postpartum depression](https://medichelpline.com/clinical-feed/medrxiv-3-motherly-plus-study-protocol-of-a-randomized-controlled-trial-evaluating-a.md)
- [REMI: Free tool enabling truncated proximity searches in PubMed](https://medichelpline.com/clinical-feed/medrxiv-23-remi-a-free-tool-for-truncated-proximity-searching-in-pubmed.md)
- [Creatine for Healthy Aging: Examining a Decade of Use](https://medichelpline.com/clinical-feed/medical-news-today-0-age-appropriate-i-ve-taken-creatine-for-10-years-does-it-help-healthy-aging.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.